TELEMAN DAN BENJAMIN (Chief Executive Officer) purchased 1.9% of their position (2.90K shares) of NASUS PHARMA LTD on the open market
Open‑market purchase worth $10.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/23/2026ACC: 0001493152-26-018607
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+2.90K
Net shares
Net buyer
$10.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.90K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+2.90K
Price / share
$3.76
Trade value
$10.90K
% of position
1.9%
4/22/2026
154.09K→156.99K
Total
Net shares
+2.90K
Net value
$10.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/22/2026 | P · Purchase | +2.90K | $3.76 | $10.90K | 1.9% | 154.09K | 156.99K |
| Total | +2.90K | $10.90K | ||||||
Derivative Transactions0
No derivative transactions reported